Bioprocess technology market valuation is anticipated to expand at a CAGR 14.8% over the forecast period of 2021 to 2031, as per the latest study by Fact.MR, a market research and competitive intelligence provider. Demand for bioprocess engineering in biotechnology is set to be valued at around US$ 78.8 Bn by 2031-e.